Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.
Panosome has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in June 2024.
Panosome's investors include German Federal Ministry of Education and Research, Business Angels, encourageventures.
Panosome is headquartered in Heidelberg, Germany.
Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.
Panosome is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Panosome — Funding & Investors." VCBacked, June 29, 2024, https://www.vcbacked.co/company/panosome. Accessed August 1, 2026.
VCBacked. (2024). Panosome — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/panosome
{{cite web |title=Panosome — Funding & Investors |url=https://www.vcbacked.co/company/panosome |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated